Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.38 |
| ▸ | SPHK2 | Q9NRA0 | 4/20 | 0.37 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | CETP | P11597 | 3/20 | 0.37 |
| ▸ | GMNN | O75496 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | GLA | P06280 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | CXCR5 | P32302 | 2/20 | 0.37 |
| ▸ | CCR6 | P51684 | 2/20 | 0.37 |
| ▸ | BLM | P54132 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1486690 | 1.00 | MEN1 (0.39) | MEN1KMT2ACYP3A4PTGS1PPARG | |
| SCHEMBL28474387 | 1.00 | MEN1 (0.39) | MEN1KMT2ACYP3A4PTGS1PPARG | |
| SCHEMBL2005037 | 0.93 | MEN1 (0.47) | MEN1KMT2ACYP3A4PTGS1PPARG | |
| SCHEMBL2005039 | 0.93 | MEN1 (0.47) | MEN1KMT2ACYP3A4PTGS1PPARG | |
| SCHEMBL2008600 | 0.91 | MEN1 (0.50) | MEN1KMT2ACYP3A4PTGS1PPARG | |
| SCHEMBL11972970 | 0.91 | MEN1 (0.50) | MEN1KMT2ACYP3A4PTGS1PPARG | |
| SCHEMBL11972972 | 0.91 | MEN1 (0.50) | MEN1KMT2ACYP3A4PTGS1PPARG | |
| SCHEMBL2008602 | 0.91 | MEN1 (0.50) | MEN1KMT2ACYP3A4PTGS1PPARG | |
| SCHEMBL2008705 | 0.85 | MEN1 (0.39) | MEN1KMT2ACYP3A4PTGS1PPARG | |
| SCHEMBL2008706 | 0.85 | MEN1 (0.39) | MEN1KMT2ACYP3A4PTGS1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118139527-A | Ant control agent and ant control method | 信越化学工业株式会社 | 2024-06-04 | — | — | CN | disclosed |
| CN-106883899-B | Preparation method of poly alpha-olefin synthetic oil with high viscosity index | 中国石油天然气股份有限公司 | 2019-11-08 | — | — | CN | disclosed |
| CN-106881119-B | Catalyst for poly α -olefin synthetic oil and preparation method thereof | 中国石油天然气股份有限公司 | 2019-08-02 | — | — | CN | disclosed |
| EP-2678410-B1 | COMPOSIITONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES | PROCTER & GAMBLE (US) | 2017-09-13 | — | — | EP | disclosed |
| EP-3178831-A1 | HETEROLEPTIC IRIDIUM COMPLEX | Universal Display Corporation (US) | 2017-06-14 | — | — | EP | disclosed |
| US-9193937-B2 | Mixtures of C10-C13 alkylphenyl sulfonates | THE PROCTER & GAMBLE COMPANY (US) | 2015-11-24 | — | — | US | disclosed |
| US-8481324-B2 | Apparatus and methods for diagnosing renal disorders | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2013-07-09 | — | — | US | disclosed |
| WO-2012138423-A1 | COMPOSITIONS COMPRISING MIXTURES OF C10-C13 ALKYLPHENYL SULFONATES | THE PROCTER & GAMBLE COMPANY (US) | 2012-10-11 | — | — | WO | disclosed |
| US-20120214724-A1 | Mixtures OF C10-C13 Alkylphenyl Sulfonates | THE PROCTER & GAMBLE COMPANY | 2012-08-23 | — | — | US | disclosed |
| US-20120208959-A1 | METHOD FOR PRODUCING AN AQUEOUS POLYMER DISPERSION | BASF SE (DE) | 2012-08-16 | — | — | US | disclosed |
| CN-101558119-A | Polyamide containing acrylate rubber | BASF SE (DE) | 2009-10-14 | — | — | CN | disclosed |
| US-20080221267-A1 | Process for Preparing an Aqueous Addition-Polymer Dispersion | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-11 | — | — | US | disclosed |
| US-7037989-B2 | Copolymers of ethylene and/or α-olefins and vicinally disubstituted olefins | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-05-02 | — | — | US | disclosed |
| WO-2004106394-A1 | COPOLYMERS OF ETHYLENE AND/OR α-OLEFINS AND VICINALLY DISUBSTITUTED OLEFINS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-12-09 | — | — | WO | disclosed |
| US-20040242814-A1 | COPOLYMERS OF ETHYLENE AND/OR ALPHA-OLEFINS AND VICINALLY DISUBSTITUTED OLEFINS | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-12-02 | — | — | US | disclosed |
| US-4524144-A | Alkali metal-promoted zinc titanate hydrogel catalyst for dehydrogenation of organic compounds | PHILLIPS PETROLEUM COMPANY (US) | 1985-06-18 | — | — | US | disclosed |
| US-4463213-A | PARAFFIN AND OLEFIN CONVERSION; CATALYST SELECTIVITY | PHILLIPS PETROLEUM COMPANY (US) | 1984-07-31 | — | — | US | disclosed |
| EP-0016853-A1 | Process for the dehydrogenation of acyclic paraffins or acyclic olefins and catalyst therefor | PHILLIPS PETROLEUM COMPANY (US) | 1980-10-15 | — | — | EP | disclosed |
| US-4218343-A | DEHYDROGENATION CATALYSTS | PHILLIPS PETROLEUM COMPANY (US) | 1980-08-19 | — | — | US | disclosed |
| US-4167532-A | OXIDATIVE DEHYDROGENATION OF ACYCLIC HYDROCARBONS USING A CATALYST COMPOSED OF OXIDES OF NICKEL, PHOSPHORUS, POTASSIUM, AND LEAD | PHILLIPS PETROLEUM CO. (US) | 1979-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120214724-A1 | Mixtures OF C10-C13 Alkylphenyl Sulfonates | SMURF1, C1S, SMURF2 | MEN1 2731/4885KMT2A 2595/4885CYP3A4 1963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.